The test, supported partly by funding from the National Institutes of Health, leverages biomarkers found in urine to detect ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions ...

Expert Rev Mol Diagn. 2010;10(1):49-64. With the ultimate goal of enabling personalized medicine for PC, massive efforts have been undertaken to identify new and better diagnostic, prognostic and ...

Science is not shy about ambiguity, never more so than when it comes to medical advice. So here’s the latest recommendation on prostate-cancer screening: Men should continue to have both a manual ...

Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has improved patient ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

Researchers found that analyzing certain chemokine levels may help explain racial disparities in prostate cancer lethality, and that neutralizing such chemokines could potentially benefit prostate ...

Neighborhood disadvantage is associated with greater expression of stress-related genes that are linked to more aggressive prostate cancer. Men from disadvantaged neighborhoods have higher expression ...

Microarray expression profiling of tumor samples for biomarker discovery is based on the assumption that gene expression patterns are major determinants of cancer cell behavior. Using microarray ...